Value Research Online

IPO update: Glenmark Life Sciences

Wed, 06 Oct 2021 07:00:00 +0530

Low operational costs, the China +1 strategy and the government's focus on local manufacturing are some tailwinds for the company

Wed, 04 Jul 2018 06:54:15 +0530

Here are some companies that have significantly grown and shrunk in size over the last 10 years

Thu, 17 May 2018 08:00:00 +0530

Banking on a process driven approach, Mahesh Patil is an expert picker of growth opportunities

Wed, 16 May 2018 08:00:00 +0530

Chirag Setalvad likes to invest in non glamorous companies that have sound cash flows and are backed by competent managements

Thu, 10 Dec 2015 11:38:29 +0530

With high numbers of ANDAs, mid-rung pharma companies could outperform their larger peers in the future>

Tue, 20 Oct 2015 17:56:55 +0530

There is little value in the stocks of the three main defensive sectors: FMCG, pharma and technology

Wed, 06 Aug 2008 12:03:00 +0530

Though this quarter's earnings growth is surprisingly ahead of expectations, concerns do remain. Here are some key points to note>

Fri, 18 Jul 2008 10:06:00 +0530

Shankar Sharma, Director & Chief Global Trading Strategist, First Global>

Tue, 20 May 2008 14:32:00 +0530

Pharma funds have staged a smart recovery after posting negative returns for the past few years>

Mon, 01 Jan 2007 13:35:00 +0530

Glenmark is leaving no stone unturned to become a formidable pharma player>